DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **Charity Number: 1176307**
**The ecancer Global Foundation FINANCIAL STATEMENTS**
**For the Year Ended 31 December 2021**
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The ecancer Global Foundation FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
|**C O N T E N T S**||
|---|---|
||**Page**|
|LEGAL AND ADMINISTRATIVE DETAILS|1|
|TRUSTEES’ REPORT|2 - 5|
|INDEPENDENT EXAMINERS’ REPORT|6|
|STATEMENT OF FINANCIAL ACTIVITIES|7|
|BALANCE SHEET|8|
|NOTES TO THE FINANCIAL STATEMENTS|
9-13|
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The ecancer Global Foundation FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
**Principal address** The ecancer Global Foundation 13 King Square Avenue Bristol BS2 8HU **Independent Examiners** Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT
## **Trustees:**
The trustees who served during the year were:
Emily Sarah Kobbe Penelope Jane Crocker Professor Richard Sullivan James Isola Cristian Herra (appointed 1 June 2022) Groesbeck Parham (appointed 1 June 2022)
- 1 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The** _**e**_ **cancer Global Foundation TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021**
## **Message from the chair**
2021 has been a year of uncertainty for the world as society manages a return to a new normal in coping with the ongoing pandemic. The global oncology community, including ecancer, are not immune to these circumstances, as such, 2021 has been a year of tentatively edging towards pre-pandemic activity where appropriate.
One of the biggest challenges for ecancer is to maintain the momentum in terms of the increased interest in online learning during the heights of the pandemic. Our overall engagement with healthcare professionals through ecancer.org has dipped by 2% over the year but, based on the significant increase in 2020, we are Prof Richard Sullivan satisfied with the result .
2021 was the first full year of the new submission criteria for our Journal, ecancermedicalscience, where we proactively support the publication of research from Low- and Middle- Income Countries (LMICs) and other resource limited settings. Therefore, it was gratifying to see that we only experience a 1% drop in the number of articles publish when compared to 2020.
In 2022, we’re looking forward to the return of international travel which will hugely impact our Video and Events Teams who will be able to attend global conferences as well as running face to face events respectively. Towards the end of 2021 we secured funding which will allow a significant increase in the number of events we will run and the number of online resources we can provide specifically to support oncology professionals in LMICs. This is hugely exciting for the organisation and means that we can look forward positively to making a positive impact on the education of the global oncology community.
As always, we are hugely appreciative to the individuals and organisations who we work with to improve care for cancer patients across the world. Without their support our work would not be possible and we are forever mindful of this.
Prof Richard Sullivan – Chair of Trustees
- 2 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The** _**e**_ **cancer Global Foundation TRUSTEES’ REPORT CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2021**
## **Report of the Trustees**
The Trustees hereby present the statutory report, with the accounts of The ecancer Global Foundation, for the year ending 31 December 2021.
The results for the year are presented in the form of a Statement of Financial Activities, which incorporates the traditional income and expenditure account, in order to comply with the Statement of Recommended Practice for Charities, and in accordance with the Charities Act 2011.
## **The Trust**
The accounts accompanying this report are the accounts of the charitable trust. It is registered with the Charities Commission, Charity Registration number 1176307.
## **Charitable objectives**
Our vision
A world in which every cancer patient receives the best possible care and treatment.
## **Our mission and future plans**
_e_ cancer's mission is to raise the standards of care for cancer patients across the world through education. Throughout the next 12 months, the charity will focus on managing the post Brexit process, as well as managing the transition to a post COVID world. The charity also aims to build on the success of 2021 and to increase the levels of income while effectively managing expenditure.
Another key future plan for the charity is to recruit the first Individual Giving Fundraiser and develop a comprehensive fundraising strategy.
## **Public benefit statement:**
The ecancer Global Foundation’s charitable purpose is carried out for the public benefit in accordance with our vision and mission. The Trustees confirm that they have complied with the duty in Section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s general guidance on Charities and Public Benefit.
## **Educational activities for healthcare professionals**
The majority of the oncology professionals who engage with our educational resources do so through our open access and free website, ecancer.org. The site provides a vast knowledge bank covering every cancer type which are developed in partnership with leading global experts to meet regional educational needs. ecancer.org has been publishing free education for the oncology community since 2007 and, as such, has an established audience from around the world.
As well as ecancer.org, our ethos is to provide educational resources to the global oncology community wherever there is a need to as wide an online audience as possible. Our resources are therefore also disseminated through platforms such as YouTube, PubMed, Twitter, Facebook, LinkedIn, Scopus, Web of Science, Embase, EBSCO and Google Scholar as well as other educational partners such as the Union for International Cancer Control (UICC), the International Cancer Control Partnership and the International Society for Geriatric Oncology (SIOG).
A section of ecancer.org is dedicated to healthcare professionals in Latin America with content in predominantly in Spanish but also in Portuguese. We have native Spanish speakers who manage and maintain this section with support from our other team members.
We also publish ecancerpatient.org which is a patient-focused website that provides the latest cancer information direct from experts in an easy-to-understand format that was developed in partnership with patient groups. The goal is to empower patients to be more involved in the decision-making process when it comes to their care.
Our series of educational events in under-served areas of the world is now well established in Latin America and has launched in India with fantastic educational partners allowing us to deliver high quality education in areas of the world that need it most.
- 3 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The** _**e**_ **cancer Global Foundation TRUSTEES’ REPORT CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2021**
Key 2021 highlights (figures in brackets show change from 2020) ecancer.org
- 714,708 learners (↓2%)
- 4,931 new registrations (↓15%)
Video
- -628 videos published (↓19%)
- -Our videos were viewed a total of 1,532,644 times (↑7%)
- -Filmed at 28 conferences (↑8%), including:
- 2021 ASCO Annual Meeting
- ESMO 2021 Congress
- EHA 2021
- ASH 2021
- SABCS2021
## Journal (ecancermedicalscience)
-402 (↓16%) submitted articles in English and Spanish
-177 published articles (↓1%) with translations if required
- -Our articles were read 1,254,980 times (↑8%)
- -Published four special issues (↑33%)
- Oncology nursing in the Global South during COVID-19
- Cancer Health Disparities: The ReTOOL Programme Findings
- African model(s) for capacity building in women’s cancer care in fragile, conflict-impacted ecosystems
- Oncology education in Africa: progress through innovation and collaboration
e-learning
- -3 new courses published (↑0%)
- -6,354 modules completed (↑20%)
- -New courses include:
- Coding a cancer case: topology, morphology and stage
- Paediatric cancer staging: Bone and soft tissue sarcoma
- Paediatric cancer staging: solid tumours
## News
-2,067 (1,657 in English and 410 in Spanish) stories were published from leading oncology sources (↓3%) -Our news stories were read 444,120 times (↑27%)
- -Our five most viewed stories were:
- Bicarbonato: Un arma contra el cáncerResearch projects
- Anestesia, contraindicaciones y complicaciones: 3 claves para entender qué ocurre durante una endoscopía
- El casabe combate el colesterol y previene el cáncer de colon
- Researchers find possible markers for earlier diagnosis of aggressive tongue cancer
- Adenopatía axilar por vacunación COVID-19 detectada durante la toma de imágenes de la mama
-We are partners in projects funded by the Medical Research Council and the Innovative Medicines Initiative:
- Re-IMAGINE - Correcting 40 years of risk-stratification error in early prostate cancer
- PIONEER – The European Network of Excellence for Big Data in Prostate Cancer
## Events
-We ran six events (↑20%). Six virtual events were held in collaboration with regional and international partners including the Union for International Cancer Control (UICC),
Sociedad Lationamericana y del Caribe de Oncologia Medica (SLACOM), Liga Colombiana Contra el Cancer and the National Cancer Grid of India.
- Chennai: Choosing Wisely /Avoiding Wisely for LMICs: Call for action
- • Fight Against Cancer - Prevent, Cure and Care in Niger • Kolkata: **Oncology Skills course** 2021 • Symposio ecancer en cuidados paliativos
- Simposio ecancerpatient: Inclusión, Respeto y Dignidad
- Congreso ecancerpatient 2021
- -6,535 healthcare professionals have accessed these events with international and regional speakers (↑11%)
- 4 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The** _**e**_ **cancer Global Foundation TRUSTEES’ REPORT CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2021**
## **Trustee Recruitment and training programme**
The existing Trustees and CEO review any gaps in the group of Trustees on an ongoing basis, and if there is a shortage, will review suitable individuals who fit the requirements profile. Any individual is then approached and recruited, and follows the charity’s training and induction process.
Pay and remuneration is reviewed on an annual basis as part of the budgeting process, and is agreed at Trustee level.
## **Decision making**
The charity is managed by the CEO, with support from the Senior Management Team. Key decisions likely to significantly impact the organisation are agreed by the CEO and Trustees, who review and evaluate in detail.
## **Risk Assessment**
In accordance with the SORP requirements, the Trustees carry out wide-ranging reviews of the risks faced by the charity. These reviews look particularly at Health and Safety issues, management and financial accountability and internal security. The Trustees are satisfied that all appropriate and feasible measures have been put in place to reduce the risks to which the charity is exposed. As a consequence of this, the Trustees have greater awareness of the kinds of risks which could affect the charity and have implemented strategies to reduce such risks.
## **Reserves policy and financial position**
As a young charity, we are currently in the process of building reserves to achieve the aims of the organisation which is to maintain free unrestricted reserves:
- To provide a level of working capital that protects the continuity of our core work;
- To provide a level of funding for unexpected opportunities; and
- To provide cover for risks such as unforeseen expenditure or unanticipated loss of income.
- The charity’s reserves at 31 December 2021 stood at £184,295 (2020 – £59,018).
- Of this, £28,383 (2020 - £15,813) represents restricted reserves, therefore free reserves stood at £155,912 (2020 – £43,205).
## **STATEMENT OF TRUSTEES’ RESPONSIBILITIES**
The Trustees of the Charity are required to prepare for each financial year accounts which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources of the Charity for that period. In preparing those financial statements, the trustees are required to:
- select suitable accounting policies and then apply them consistently;
- make judgements and estimates that are reasonable and prudent; state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that this basis applies.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Trust Deed dated 5 June 1956. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 11/11/2022
Approved by the Trustees on …………..…… and signed as authorised
…………………………….. Prof. Richard Sullivan
- 5 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The ecancer Global Foundation INDEPENDENT EXAMINERS’ REPORT TO THE DIRECTORS OF THE TRUSTEE COMPANY FOR THE YEAR ENDED 31 DECEMBER 2021**
I report on the accounts of The _e_ cancer Global Foundation for the year ended 31 December 2021, which are set out below.
## **Respective responsibilities of trustees and examiner**
The trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for this year (under section 144 of the Charities Act 2011 (the Act)) and that an independent examination is needed. It is my responsibility to:
- examine the accounts (under section 145 of the Act);
- to follow the applicable directions given by the Charity Commission (under section 145(5)(b) of the Act); and
- to state whether particular matters have come to my attention.
## **Basis of independent examiners’ report**
My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a ‘true and fair’ view and the report is limited to those matters set out in the statement below.
## **Independent examiners’ statement**
In connection with my examination, no material matter has come to my attention which gives me cause to believe that, in any material respect:
- the accounting records were not kept in accordance with Section 130 of the Act; or
- the accounts did not accord with the accounting records; or
- the accounts did not comply with the accounting requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008, other than any requirement that the accounts give a ‘true and fair’ view, which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
……………………………… **Martin Howard FCA**
11/11/2022
**Date:** ……………..
**Hazlewoods LLP Chartered Accountants**
- 6 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The** _**e**_ **cancer Global Foundation STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2021**
|**INCOMING**
**RESOURCES**
**Unrestricted**
**funds**
**Notes**
Donations and
legacies
**_Charitable_**
**_Activities_**
E-learning
Events
Journal
Research projects
Educational video
Website
**_Other Activities to_**
**_Generate_**
**_Funds_**
Advertising income
**Total Incoming**
**Resources**
**Resources**
**Expended**
Raising funds
**_Charitable_**
**_Expenditure_**
E-learning
Events
Journal
Research projects
Educational videos
Website
Advertising
**Total Resources**
**Expended**
**2**
**Net movements in**
**funds**
Transfer between
funds
**Total funds**
**brought forward**
**Balance carried**
**forward at 31**
**December 2021**|**Unrestricted**
**funds**
**2021**
**£**
254
43,713
11,130
20,997
-
374,832
22,900
52,876
**526,702**
57,881
3,009
26,754
96,173
-
184,870
65,829
411
192,965
**434,927**
91,775
20,932
43,205
**155,912**|**Restricted**
**funds**
**2021**
**£**
-
67,209
-
-
-
294,927
-
-
**362,136**
**-**
73,459
30,756
-
-
224,419
-
-
328,634
**328,634**
33,502
(20,932)
15,813
**28,383**|**Total**
**funds 2021**
**£**
254
110,922
11,130
20,997
-
669,759
22,900
52,876
**888,838**
57,881
76,468
57,510
96,173
-
409,289
65,829
411
521,599
**763,561**
125,277
-
59,018
**184,295**|**Total funds**
**2020**
**£**
1,185
106,556
65,180
20,346
41,144
725,156
-
71,178|
|---|---|---|---|---|
|||||**1,030,745**|
|||||-
102,686
139,828
72,550
35,643
493,428
-
-|
|||||844,136|
||||||
|||||**844,136**|
|||||186,609
-
(127,591)|
|||||**59,018**|
- 7 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The ecancer Global Foundation BALANCE SHEET AT 31 DECEMBER 2021**
|**Note**
**Fixed assets**
**3,7**
**Current Assets**
Debtors and prepayments
**4,7**
Cash at bank and in hand
**Less Creditors: Amounts**
**falling due within one year**
**5,7**
**Net Current Assets**
**Net Assets**
**Represented by:**
Unrestricted funds:
**6**
Restricted funds
**6**|**2021**
2,245
183,455
595,745
779,200
(597,150)
182,050
184,295
155,912
28,383
184,295|**2020**
**£**
2,063
145,770
158,515|
|---|---|---|
|||304,285
(247,330)
56,955|
|||59,018|
|||43,205
15,813|
|||59,018|
11/11/2022
Approved by the trustees on ………………. and signed on their behalf by:
………………….. Prof R Sullivan
- 8 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The ecancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
## **1. Accounting Policies**
## **Basis of Preparation**
The financial statements have been prepared under the historical cost convention, as modified by the revaluation of certain fixed assets, adopting the following principal accounting policies all of which are in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Charities Act 2011.
## **General information**
The financial statements are presented in Pounds Sterling. The charity is a public benefit charitable incorporated organisation, incorporated in England and Wales.
The address of its registered office is: 13 King Square Avenue Bristol BS2 8HU
## **Judgements and estimation uncertainty**
The trustees consider that there are no key areas of judgement or estimation uncertainty to be disclosed in these financial statements.
## **Tangible fixed assets and depreciation**
Tangible fixed assets are stated in the accounts at cost or revalued amount less depreciation. Depreciation is provided at rates calculated to write off the cost of each asset over its expected useful life.
Depreciation is provided to write off the cost/value of assets over their useful lives as follows:
Office equipment 5 years
## **Cash and cash equivalents**
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
## **Trade receivables**
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. All debtors are repayable within one year and are hence included at the undiscounted amount of the cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the Charity will not be able to collect all amounts due according to the original terms of the receivables.
## **Trade payables**
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the Charity does not have an unconditional right, at the end of the reporting year, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
- 9 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **Legacies, Donations and Grants Receivable**
All income is recognised when receivable and when capable of financial measurement. Receipts of property investments or other gifts in king are included at market value.
## **Going concern**
There are no significant factors affecting the charity’s ability to continue as a going concern.
## **Expenditure on Charitable activities**
Expenditure on Charitable activities is included in the Statement of Financial Activities on an accruals basis. Where expenditure is directly attributable to more than one activity, it is apportioned across cost categories on the basis of the proportion of income receivable relating to each activity.
## **Funds**
Funds held by the charity are either:
- Unrestricted general funds, which can be used in accordance with the charitable objects at the discretion of the Trustees; or
- Unrestricted designated funds, which can be used in accordance with the Charitable objects, in respect of specific projects ear-marked by the Trustees; or
- Restricted funds, which can only be used for particular restricted purposes within the objects of the charity. Restrictions are specified by the donor or when funds are raised for particular restricted purposes. All funds received to date have been applied against capital projects.
## **Pensions**
The company operates a defined contribution scheme for certain employees. The contributions are charged to revenue in the year in which they are incurred.
## **2. Analysis of Total Resources Expended**
|**_Charitable Expenditure_**
E-learning
Events
Journal
Research projects
Educational videos|**Direct**
**Activities**
**£**
-
-
81,785
-
-
**81,785**|**Grant**
**funding**
**£**
70,744
66,117
-
23,264
242,831
**402,956**|**Support**
**costs**
**(see 2a**
**below) £**
5,724
5,604
14,388
3,121
48,209
**77,046**|**2021**
**Total**
**£**
76,468
71,721
96,173
26,385
291,040
**777,774**|**2020**
**Total**
**£**
121,075
145,396
123,882
42,680
411,103|
|---|---|---|---|---|---|
||||||**844,136**|
Support costs are allocated on the basis of full-time equivalents.
|**Staff costs:**
Wages and salaries
Social security costs
Pension costs
The average number of full time employees
In the period was|**2021**
**£**
470,796
39,880
34,992
545,668
**Number**
18|**2020**
**£**
451,355
37,347
35,670|
|---|---|---|
|||524,372|
|||**Number**
17|
No employee earned £60,000 or more, and no Trustees were remunerated through the charity.
- 10 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The ecancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
## **2a. Analysis of Support Costs**
|Raising funds
E-learning
Events
Journal
Research projects
Educational videos|**2021**
**£**
-
5,724
5,604
14,388
3,121
48,209
77,046|**2020**
**£**
-
9,063
11,361
18,534
5,049
68,097|
|---|---|---|
|||112,104|
Support costs are all allocated to charitable expenditure, other than £nil (2020 - £nil) incurred in relation to raising funds within the year.
Independent examination fees accrued during the year was £3,000, (2021 - £6,000 audit fees). No other services were provided by the auditors.
## **3. Fixed assets**
|**Cost**
At 1 January 2021
Additions
December 31, 2021
**Depreciation**
At 1 January 2021
Charge for the year
December 31, 2021
**Net book value**
December 31, 2021
December 31, 2020
**.**
**Debtors**
Trade debtors
Prepayments and accrued income|**Office**
**equipment**
**£**
2,556
812
3,368
493
630
1,123
**2,245**
**2,063**
**2021**
**£**
179,548
3,907
183,455||**Total**
**£**|
|---|---|---|---|
||||2,556
812|
||||3,368|
||||493
630|
||||1,123|
|||||
||||**2,245**|
|||||
||||**2,063**|
||||**2020**
**£**
64,483
81,287|
||||145,770|
## **4. Debtors**
- 11 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The** _**e**_ **cancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
## **5. Creditors: Amounts falling due within one year**
|Trade creditors
Taxation and social security
Accruals and deferred income
Other creditors|**2021**
**£**
7,684
11,685
568,086
9,695
597,150|**2020**
**£**
23,516
10,391
207,818
5,605|
|---|---|---|
|||247,330|
Included within accruals and deferred income is £565,086 (2020 - £199,718) in relation to income deferred on performance-related grants. These grants are considered to contain conditions that require the charity to undertaken certain activities before it becomes fully entitled to the respective grant monies.
Reconciliation of deferred income
|At 1 January 2021
Deferred income released
Additional deferred income
At 31 December 2021|**Deferred income**
**£**
199,718
(216,640)
582,008|
|---|---|
||**565,086**|
## **6. Funds**
|General fund
**_Restricted_**
**_fund_**
E-learning
Events
Journal
Research
Educational
videos
Transfer
between funds|**1 January**
**2021**
**£**
43,205
-
-
-
5,501
10,312
-
**59,018**|**Incoming**
**resources**
**£**
526,702
67,209
-
-
-
294,927
-
**888,838**|**Transfer**
**between**
**funds**
**£**
20,932
6,250
30,756
-
-
(57,938)
-
**-**|**Outgoing**
**resources**
**£**
(434,927)
(73,459)
(30,756)
-
-
(224,419)
-
**(777,774)**|**31 December**
**2021**
**£**
155,912
-
-
5,501
22,882
-
-|
|---|---|---|---|---|---|
||||||**184,295**|
The restricted funds are held separately as they relate to specific performance related grant funds and expenditure. They represent various projects for which the donors have specified the use of the funds. These have been grouped into various categories for the purpose of the note above.
A transfer has been made between the funds to correct amounts incorrectly treated in the prior year, as well as to clear out negative restricted fund balances at year end, and move the deficit back to general funds.
- 12 -
DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC
## **The** _**e**_ **cancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021**
## **7. Reconciliation of funds per asset/liability**
|Fixed assets
Cash at bank and
in hand
Current assets
Current liabilities
Fixed assets
Cash at bank and
in hand
Current assets
Current liabilities|**Unrestricted**
**funds**
**£**
2,245
595,745
183,456
(31,299)
**750,147**
**Unrestricted**
**funds**
**£**
2,063
158,515
66,370
(47,612)
**179,336**|**Restricted**
**funds**
**£**
-
-
-
(565,806)
**(565,806)**
**Restricted**
**funds**
**£**
-
-
79,400
(199,718)
**(120,318)**|**2021**
**Total**
**£**
2,245
595,745
183,456
(597,105)|
|---|---|---|---|
||||**184,341**|
||||**2020**
**Total**
**£**
2,063
158,515
304,284
(247,330)|
||||**59,018**|
## **8. Related party transactions**
The charity has no related party transactions to disclose.
- 13 -